Skip to main content
. 2021 Dec 22;14(1):39. doi: 10.3390/cancers14010039

Figure 3.

Figure 3

Kaplan–Meier survival analysis of INA (a), NHLH2 (b) and THBS4 (c) and progression free survival. Blue curve, patients with methylation levels above the gene-specific optimum cut-off. Red curve, patients with methylation levels below the gene-specific optimum cut-off. Optimized cut-off values applied for dichotomization were 24% (INA), 11% (NHLH2), and 25% (THBS4).